NeDiPal received approval from the Commissie Medische Ethiek (CME) of the Universitair Ziekenhuis (UZ) Brussel. With that, it completed the Green Light procedure.
After several months of preparation, the research project has received approval from the local ethics committee. This process was particularly insightful, as Belgium applies very strict regulations not only to clinical trials involving investigational products, but also to qualitative sociological studies. Due to these high standards, NeDiPal has been approved as an interventional clinical trial, which further strengthens the project’s credibility in terms of ethics, security, and data protection.
With this approval, the empirical phase of the research can now begin. NeDiPal is therefore entering a new stage of the project. Stay tuned for further updates.